IL1B and COVID-19: Finally, interleukin-18 is a highly predictive biomarker of death by COVID-19 [65], and measurements in bronchoalveolar lavage fluid (BALF) showed a significant increase in the interleukin-1β (IL-1β) level in patients with moderate to severe COVID-19 [66].